D. Western Therapeutics Institute (4576 JP) - News Flash
The number of patients is 200 cases in 4 groups: H-1337 0.6% (twice daily), 1.0% (twice daily), 1.0% (once daily), and Timolol (beta blocker drug...
440 Views
D. Western Therapeutics Institute (DWTI) (4576 JP) - New Fundraising Secured in June
in Japan, start P2 clinical trials in 2024, P3 trials in late 2025 though 2026, and normal schedule application for approval for regenerative cell...
163 Views
D. Western Therapeutics Institute (4576 JP) - Flurry of Pipeline Activity in 2023
Major milestones with high expectations coming in the next 2-3 years: 1) Phase IIb US trials for H-1337 as “first choice as a second-line Glaucoma...
506 Views
4Q Follow-Up -D. Western Therapeutics Institute (DWTI) | 4576
Major milestones with high expectations coming in the next 2-3 years: 1) Phase IIb US trials for H-1337 as “first choice as a second-line Glaucoma...
393 Views
3Q Follow-Up - D. Western Therapeutics Institute (DWTI) (4576 JP)
Major milestones with high expectations coming in the next 2-3 years: 1) Phase IIb US trials for H-1337 as “first choice as a second-line Glaucoma...
504 Views